---
figid: PMC6993488__12943_2020_1144_Fig3_HTML
figtitle: Inhibiting T cell activity causes anti-PD-1/PD-L1 immunotherapy resistance
organisms:
- Homo sapiens
- Mus musculus
- Nicotiana tabacum
- gut metagenome
- Human gammaherpesvirus 4
- Akkermansia muciniphila
- NA
pmcid: PMC6993488
filename: 12943_2020_1144_Fig3_HTML.jpg
figlink: pmc/articles/PMC6993488/figure/Fig3/
number: F3
caption: Inhibiting T cell activity causes anti-PD-1/PD-L1 immunotherapy resistance.
  After PD-1 blockade, the secretion of cytokines, including TNF and IF-36, causes
  T cell gene alterations, which inhibits cytotoxicity, promotes TIM-3 and VISTA inhibitory
  checkpoint expression, up-regulates CD38, and promotes ATRA secretion and binding
  to adenosine receptor and adenosine inhibition of T cell activation. The deletion
  of PTEN in tumors activates the PI3K/AKT pathway through multiple routes, including
  phosphorylation of Akt and activation of S6K1, to promote PD-L1 expression and inhibit
  T cell activation
papertitle: Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1
  blockade cancer immunotherapy.
reftext: Daixi Ren, et al. Mol Cancer. 2020;19:19.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9453697
figid_alias: PMC6993488__F3
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC6993488__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6993488__12943_2020_1144_Fig3_HTML.html
  '@type': Dataset
  description: Inhibiting T cell activity causes anti-PD-1/PD-L1 immunotherapy resistance.
    After PD-1 blockade, the secretion of cytokines, including TNF and IF-36, causes
    T cell gene alterations, which inhibits cytotoxicity, promotes TIM-3 and VISTA
    inhibitory checkpoint expression, up-regulates CD38, and promotes ATRA secretion
    and binding to adenosine receptor and adenosine inhibition of T cell activation.
    The deletion of PTEN in tumors activates the PI3K/AKT pathway through multiple
    routes, including phosphorylation of Akt and activation of S6K1, to promote PD-L1
    expression and inhibit T cell activation
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NT5E
  - CD274
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD38
  - PTEN
  - HAVCR2
  - VSIR
  - CD8A
  - CD8B
  - TNF
  - Akt1
  - Pik3r1
  - Nt5e
  - Cd274
  - Pdcd1
  - Cd38
  - Pten
  - Havcr2
  - Vsir
  - Tnf
  - Adenosine
  - ATRA
---
